Literature DB >> 19451069

Interstitial lung disease associated with oxaliplatin: description of two cases.

C Pena Alvarez, H J Suh Oh, A Sáenz de Miera Rodríguez, F R García Arroyo, M Covela Rúa, L Salgado Boquete, P M López Clemente, M Constenla Figueiras.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19451069     DOI： 10.1007/s12094-009-0364-4

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  5 in total

1.  Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy.

Authors:  R Trisolini; L Lazzari Agli; D Tassinari; D Rondelli; A Cancellieri; M Patelli; F Falcone; V Poletti
Journal:  Eur Respir J       Date:  2001-07       Impact factor: 16.671

2.  Interstitial pneumonitis after oxaliplatin treatment in colorectal cancer.

Authors:  Xavier Hernández Yagüe; Ester Soy; Bernardo Queralt Merino; Josep Puig; Miguel Beltrán Fabregat; Ramón Colomer
Journal:  Clin Transl Oncol       Date:  2005-12       Impact factor: 3.405

3.  Cryptogenic organizing pneumonitis during oxaliplatin chemotherapy for colorectal cancer: case report.

Authors:  Marcelo Garrido; Andrés O'Brien; Sergio González; José Miguel Clavero; Eric Orellana
Journal:  Chest       Date:  2007-12       Impact factor: 9.410

4.  Pulmonary fibrosis after chemotherapy with oxaliplatin and 5-fluorouracil for colorectal cancer.

Authors:  Pamela Mundt; Hans-Christian Mochmann; Harald Ebhardt; Martin Zeitz; Rainer Duchmann; Matthias Pauschinger
Journal:  Oncology       Date:  2008-04-17       Impact factor: 2.935

5.  Fatal pneumonitis induced by oxaliplatin.

Authors:  Sara Arévalo Lobera; Naiara Sagastibeltza Mariñelarena; Ibone Elejoste Echeberría; Mireia Melé Olivé; Larraitz Egaña Otaño; Laura Basterretxea Badiola; Adelaida La Casta Muñoa; Mikel Azkue Gabilondo
Journal:  Clin Transl Oncol       Date:  2008-11       Impact factor: 3.405
  5 in total
  5 in total

1.  Fatal interstitial pneumonia associated with oxaliplatin-based therapy in a patient with metastatic rectal cancer.

Authors:  Satoshi Ishizone; Naohiko Koide; Noriyuki Akita; Fumitoshi Karasawa; Nobumitsu Kobayashi; Tomonobu Koizumi; Shinichi Miyagawa
Journal:  Clin J Gastroenterol       Date:  2011-03-24

2.  Oxaliplatin-induced lung injury with allergic reaction.

Authors:  Tetsuya Homma; Masatsugu Kurokawa; Yoshitaka Yamamoto; Satoshi Matsukura; Koushi Ieki; Shintaro Suzuki; Miho Odaka; Shin Watanabe; Munehiro Yamaguchi; Mitsuru Adachi
Journal:  Chin J Cancer Res       Date:  2011-09       Impact factor: 5.087

3.  Interstitial lung disease in a patient treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) for metastatic colorectal cancer.

Authors:  Liam M Hannan; Jaclyn Yoong; Geoffrey Chong; Christine F McDonald
Journal:  Radiol Oncol       Date:  2012-11-09       Impact factor: 2.991

4.  Oxaliplatin-Induced Pulmonary Toxicity in Gastrointestinal Malignancies: Two Case Reports and Review of the Literature.

Authors:  Mor Moskovitz; Mira Wollner; Nissim Haim
Journal:  Case Rep Oncol Med       Date:  2015-05-10

Review 5.  Prognosis and treatment of FOLFOX therapy related interstitial pneumonia: a plea for multimodal immune modulating therapy in the respiratory insufficient patient.

Authors:  Annick De Weerdt; Amélie Dendooven; Annemie Snoeckx; Jan Pen; Martin Lammens; Philippe G Jorens
Journal:  BMC Cancer       Date:  2017-08-29       Impact factor: 4.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.